The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ghosh Anirvan since 2022.
This trader's CIK number is 1807437.
At the time of last reporting, Ghosh Anirvan was the Chief Executive Officer of Unity Biotechnology, Inc.. (stock ticker symbol UBX).
Also see all insider trading activities at Unity Biotechnology, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | UBX | 0 | $0 | 97,439 | $101,131 | 0 | $0 |
| 2024 | UBX | 0 | $0 | 4,716 | $7,298 | 0 | $0 |
| 2023 | UBX | 0 | $0 | 15,339 | $47,762 | 0 | $0 |
| 2022 | UBX | 0 | $0 | 23,694 | $16,802 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-02 | UBX | Sale | 96,797 | 1.03 | 99,700 |
| 2025-02-04 | UBX | Sale | 642 | 2.23 | 1,431 |
| 2024-11-04 | UBX | Sale | 432 | 1.29 | 557 |
| 2024-08-02 | UBX | Sale | 604 | 1.53 | 924 |
| 2024-06-25 | UBX | Sale | 1,214 | 1.40 | 1,699 |
| 2024-05-02 | UBX | Sale | 603 | 1.55 | 934 |
| 2024-02-02 | UBX | Sale | 680 | 1.71 | 1,162 |
| 2024-01-30 | UBX | Sale | 1,183 | 1.71 | 2,022 |
| 2023-11-02 | UBX | Sale | 589 | 1.83 | 1,077 |
| 2023-10-30 | UBX | Sale | 1,024 | 1.90 | 1,945 |
| 2023-09-14 | UBX | Sale | 1,246 | 2.47 | 3,077 |
| 2023-08-02 | UBX | Sale | 581 | 2.94 | 1,708 |
| 2023-07-31 | UBX | Sale | 1,020 | 2.86 | 2,917 |
| 2023-06-26 | UBX | Sale | 1,177 | 3.20 | 3,766 |
| 2023-06-14 | UBX | Sale | 1,212 | 3.39 | 4,108 |
| 2023-05-02 | UBX | Sale | 588 | 2.17 | 1,275 |
| 2023-05-01 | UBX | Sale | 1,020 | 2.15 | 2,193 |
| 2023-03-31 | UBX | Sale | 1,959 | 1.70 | 3,330 |
| 2023-03-14 | UBX | Sale | 1,210 | 4.00 | 4,840 |
| 2023-02-02 | UBX | Sale | 2,573 | 4.84 | 12,453 |
| 2023-01-30 | UBX | Sale | 1,140 | 4.45 | 5,073 |
| 2022-11-03 | UBX | Sale | 1,099 | 2.40 | 2,637 |
| 2022-08-01 | UBX | Sale | 10,446 | .67 | 6,998 |
| 2022-06-27 | UBX | Sale | 12,149 | .59 | 7,167 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ghosh Anirvan (Chief Executive Officer of Unity Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.